Eagle Pharmaceuticals, Inc. (EGRX)
NASDAQ: EGRX · IEX Real-Time Price · USD
5.71
-0.16 (-2.73%)
Jul 22, 2024, 10:21 AM EDT - Market open
Eagle Pharmaceuticals Employees
Eagle Pharmaceuticals had 134 employees as of December 31, 2022. The number of employees increased by 32 or 31.37% compared to the previous year.
Employees
134
Change (1Y)
32
Growth (1Y)
31.37%
Revenue / Employee
$1,922,022
Profits / Employee
$89,164
Market Cap
73.99M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SHL Telemedicine | 583 |
MDxHealth | 300 |
PetMed Express | 287 |
T2 Biosystems | 113 |
Kronos Bio | 63 |
Spero Therapeutics | 46 |
enVVeno Medical | 31 |
Oncolytics Biotech | 29 |
EGRX News
- 2 months ago - Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq - GlobeNewsWire
- 3 months ago - Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida - GlobeNewsWire
- 3 months ago - Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K - GlobeNewsWire
- 5 months ago - Shareholders of Eagle Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before February 9, 2024 to Discuss Your Rights - EGRX - Accesswire
- 5 months ago - EAGLE PHARMACEUTICALS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options - PRNewsWire
- 5 months ago - Levi & Korsinsky Reminds Eagle Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 9, 2024 - EGRX - Accesswire
- 5 months ago - Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 9, 2024 in Eagle Pharmaceuticals, Inc. Lawsuit - EGRX - Accesswire
- 5 months ago - Eagle Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 9, 2024 to Discuss Your Rights - EGRX - PRNewsWire